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ͦAbstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S127networks. Data was further analyzed by Ingenuity Pathways Analysis to
construct molecular functional networks and signaling pathways to dissect
pathways regulated by exercise. One-way ANOVA and a post hoc Tukey
test were used for statistical analysis.
Results. Treadmill walking immediately following initiation of MIA (1 day
post-MIA induction) demonstrated a signiﬁcant prevention of MIA
progression. However, the efﬁcacy of this intervention was signiﬁcantly
reduced when implemented on knees showing close to Grade I or greater
cartilage damage. On the contrary, TW accelerated damage in the knees
with close to Grade II cartilage pathologies. Transcriptome-wide gene
expression analysis revealed that exercise intervention started 1-day post-
MIA inception signiﬁcantly suppressed signaling networks that inhibit
matrix synthesis. In parallel, TW upregulated gene networks associated
with matrix synthesis. However, TW intervention following Grade I
damage was less effective in preventing cartilage damage and regulating
matrix synthesis. Interestingly, Asporin and networks associatedwith TGF-
b expression and signaling were the major gene products that were
regulated by TW to control matrix synthesis (Aggrecan, Collagen type II,
Matrilin, FRZB, Col 9A2 and Col9A3) and prevent cartilage damage as
evident by microscopic grading of cartilage.
ĂConclusions. The ﬁndings demonstrate that Asporin might be one of the
critical genes controlled by TW, that in turn controls expression of TGF-
b family of molecules, essential for cartilage matrix synthesis. The ﬁndings
underscore the importance of physiotherapies by showing suppression of
Asporin, an OA susceptibility gene by TW. Nevertheless, the extent of
cartilage damage at the initiation of physiotherapy is an important
determinant for the effectiveness of TW.
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Purpose: Osteoarthritis (OA) is a disease which affects joints causing
changes to joint structures speciﬁcally the cartilage. Current treatment
recommendations for OA are intended to provide patient with symptom-
atic relief. Diacerein is novel chondroprotective /connective tissue structure
modifying agent intended for the treatment of OA. Diacerein hydrolyses
into its active metabolite rhein. It selectively inhibits the synthesis of
interleukin- 1(IL-1) and down regulates the production of nitrous oxide
(NO), which are the agents responsible for the cartilage degeneration.
Nanotechnology is continuously providing new strategies to expand the
opportunity for drug delivery. Inside it, solid lipid nanoparticles (SLNs)
enhances lymphatic transport of drugs, reduces hepatic ﬁrst pass metab-
olism and improves bioavailability. Chondroitin sulfate is a kind of
glycosaminoglycan found in the extracellular matrix of the cartilage. Soft-
ening and erosion of cartilage the characteristic early lesions of OA occur in
sites of decreased chondroitin sulfate concentration. Considering all these
attributes, Diacerein loaded SLNs were prepared and thereafter it was
indirectly targeted to joint cartilage using chondroitin sulfate as carrier. On
these accounts, in the present study chondroitin sulfate was estimated in
OA experimental rat model after oral administration of two different
formulation of diacerein and compared with control.
Methods:Adult wistar rats (20020g) were divided in three different
groups (n¼8) for the study. Prior approval from institutional Animal Ethics
committee of Banaras Hindu University, Varanasi, India was taken. The
three groups were treated orally with 0.2% sodium CMC suspension of pure
drug (group 1), prepared SLNs without & with chondroitin sulfate (group 2
& 3) respectively. OA was induced chemically in the right knee of animals
using 2mg/joint intra-articular injection of sodium iodoacetae before
treatment. Treatment was started after 21 days of intra-articular injection.
Left knee of all animals were used as control. After four weeks of treatment
all animals were sacriﬁced and articular cartilage was obtained from the
knee at autopsy using a scalpel blade to cut as deeply as possible without
removing underlying bone. Samples were removed from the posterior
surface of the patella or from the condyles and patellar groove of the
femur. Ethanol fractions were prepared from cartilage samples
digestion in phosphate buffer pH 7 containing trypsin for 16 to 20 hrs at 37
[[Unsupported Character - ]]C and then homogenized for 1-2 minute. Insoluble
debris was removed by brief centrifugation. Supernatant was brought to
40%, 50% & 80% ethanol respectively by addition of ethanol and aqueous
20% potassium acetate solution. At each step supernatant was allowed to
stand overnight at 4 [[Unsupported Character - ]]C and centrifuged. All precipi-
tates were pooled, dissolved in water and were used for determination of
chondroitin sulfate. Before treatment 6 animals (2 animals / group) were
considered for arthritic control. Chondroitin sulfate was indirectly esti-
mated by decreased in absorbance of methylene blue on complexation
with chondroitin sulfate using spectrophotometry.
Results:Chondroitin sulfate concentration in articular cartilage of Normal
control, arthritic control, group1, group 2 and group 3 were found to be
12.434.3, 5.532.6, 6.512.5, 7.52.2 and 8.872.2 mg/mg wet weight of
cartilage respectively. All the values were average of six.
Conclusions: It was revealed from the study that chondroprotective
activity of diacerein can be enhanced by administration of drug in the form
of SLN and it can be further improved by delivering it with chondroitin
sulfate as carrier.ͦCartilage repair
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